One of the most representative mitochondrial diseases that benefits from stem cells therapy is mitochondrial neurogastrointestinal encephalopathy (MNGIE), which is due to thymidine phosphorylase (TP) gene mutations, leading to secondary mitochondrial DNA damage.20 This evidence concerns the gene TYMP and mitochondrial disease.